Journal of Law, Medicine and Ethics 39 (2):215-223 (2011)
|Abstract||Low opportunity cost, weak influence of quality of life in the face of death, the social value of life extension to others, shifting psychological reference points, and hope have been proposed as factors to explain why people apparently perceive marginal life extension at the end of life to have disproportionately greater value than its length. Such value may help to explain why medical spending to extend life at the end of life is as high as it is, and the various factors behind this value might provide normative rationale for that spending. Upon critical analysis, however, most of these factors turn out to be questionable or incompletely conceived; this includes hope, which is examined here in special detail. These factors help to explain complexity and nuance in the normative issues, but they do not provide adequate justification for spending as high as it often is. In any case, two additional factors must be added to the descriptive explanation of high spending, and they throw its normative justification into further doubt: the “insurance effect” and provider-created demand. Overall, the perception of especially high value of life at the end of life provides some normative justification for high spending, but seldom strong justification, and not for spending as high as it often is|
|Keywords||No keywords specified (fix it)|
|Categories||categorize this paper)|
|Through your library||Configure|
Similar books and articles
Michael A. Hitt, Orley M. Amos & Larkin Warner (1983). Social Factors and Company Location Decisions: Technology, Quality of Life and Quality of Work Life Concerns. [REVIEW] Journal of Business Ethics 2 (2):89 - 98.
Daniel Munday (forthcoming). Hope as Virtue: Opens Up a New Space for Exploring Hopefulness at the End of Life and Raises Some Interesting Questions. Philosophy, Psychiatry, and Psychology 19 (3):187-189.
Orsolya Friedrich (2013). Knowledge of Partial Awareness in Disorders of Consciousness: Implications for Ethical Evaluations? Neuroethics 6 (1):13-23.
David Nantais & Mark Kuczewski (2004). Quality of Life: The Contested Rhetoric of Resource Allocation and End-of-Life Decision Making. Journal of Medicine and Philosophy 29 (6):651 – 664.
Leigh Turner (2004). Life Extension Research: Health, Illness, and Death. Health Care Analysis 12 (2):117-129.
J. Cohen, J. van Delden, F. Mortier, R. Lofmark, M. Norup, C. Cartwright, K. Faisst, C. Canova, B. Onwuteaka-Philipsen & J. Bilsen (2008). Influence of Physicians' Life Stances on Attitudes to End-of-Life Decisions and Actual End-of-Life Decision-Making in Six Countries. Journal of Medical Ethics 34 (4):247-253.
Christopher Wareham (2012). Life Extension and Mental Ageing. Philosophical Papers 41 (3):455-477.
Gerald Dworkin (2007). Pt. IV. The End of Life. The Definition of Death / Stuart Youngner ; The Aging Society and the Expansion of Senility: Biotechnological and Treatment Goals / Stephen Post ; Death is a Punch in the Jaw: Life-Extension and its Discontents / Felicia Nimue Ackerman ; Precedent Autonomy, Advance Directives, and End-of-Life Care / John K. Davis ; Physician-Assisted Death: The State of the Debate. [REVIEW] In Bonnie Steinbock (ed.), The Oxford Handbook of Bioethics. Oxford University Press.
Kieran Mathieson (2005). Factors Predicting Intention to Enroll in a Philosophy of Life Course. Journal of Academic Ethics 2 (4):367-385.
Marie I. Kaiser (2011). The Limits of Reductionism in the Life Sciences. History and Philosophy of the Life Sciences 33 (4):453-476.
Roger Scruton (2012). Timely Death. Philosophical Papers 41 (3):421-434.
Helga Kuhse (1987). The Sanctity-of-Life Doctrine in Medicine: A Critique. Oxford University Press.
Added to index2011-05-12
Total downloads11 ( #107,366 of 722,774 )
Recent downloads (6 months)1 ( #60,541 of 722,774 )
How can I increase my downloads?